Arnold Library

Idelalisib Effectively Treats Indolent Lymphoma

Morris, Valerie (2014) Idelalisib Effectively Treats Indolent Lymphoma. Science Spotlight, 4 (3).

[img]
Preview
Text
Idelalisib Effectively Treats Indolent Lymphoma.pdf - Published Version
Available under License Creative Commons Attribution Non-commercial No Derivatives.

Download (295Kb) | Preview
Article URL: http://www.nejm.org/doi/full/10.1056/NEJMoa1314583
Item Type: Article
Additional Information: Gopal AK, Kahl BS, de Vos S, Wagner-Johnston ND, Schuster SJ, Jurczak WJ, Flinn IW, Flowers CR, Martin P, Viardot A,Blum KA, Goy AH, Davies AJ, Zinzani PL, Dreyling M, Johnson D, Miller LL, Holes L, Li D, Dansey RD, Godfrey WR, Salles GA. 2014. PI3Kδ Inhibition by Idelalisib in Patients with Relapsed Indolent Lymphoma. N Engl J Med. Epub ahead of print, doi: 10.1056/NEJMoa1314583. See also: Furman, R.R., Sharman, J.P., Coutre, S.E., Cheson, B.D., Pagel, J.M., Hillmen, P., Barrientos, J.C., Zelenetz, A.D., Kipps, T.J., Flinn, I., Ghia, P., Eradat, H., Ervin, T., Lamanna, N., Coiffier, B., Pettitt, A.R., Ma, S., Stilgenbauer, S., Cramer, P., Aiello, M., Johnson, D.M., Miller, L.L., Li, D., Jahn, T.M., Dansey, R.D., Hallek, M., O'Brien, S.M. 2014. Idelalisib and Rituximab in Relapsed Chronic Lymphocytic Leukemia. N Engl J Med. Epub ahead of publication, doi: 10.1056/NEJMoa1315226.
Collections: Science Spotlight
Depositing User: Ben Abraham
Date Deposited: 19 Mar 2015 19:13
Last Modified: 19 Mar 2015 19:13
URI: http://authors.fhcrc.org/id/eprint/685

Repository Administrators Only

View Item View Item
Fred Hutchinson Cancer Research Center
1100 Fairview Ave. N. PO Box 19024
Seattle, WA 98109

a 501(c)(3) nonprofit organization.

© Terms of Use & Privacy Policy